| scholarly article | Q13442814 |
| P50 | author | Michael Reiss | Q56547220 |
| P2093 | author name string | Susan R Rittling | |
| Craig Zetterberg | |||
| Vaishali Rajeev | |||
| Bradley Yates | |||
| P2860 | cites work | Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? | Q22251049 |
| Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism | Q24600173 | ||
| Worms gang up on bacteria | Q27860588 | ||
| TGF-beta and epithelial-to-mesenchymal transitions | Q29616456 | ||
| The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion | Q29616467 | ||
| Immortalization of multiple cell types from transgenic mice using a transgene containing the vimentin promoter and a conditional oncogene. | Q30420722 | ||
| TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition | Q33734595 | ||
| TGF-beta and cancer. | Q33804136 | ||
| Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. | Q34400238 | ||
| The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. | Q34434565 | ||
| Suppression of Egr-1 transcription through targeting of the serum response factor by oncogenic H-Ras | Q34468320 | ||
| Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation | Q34563192 | ||
| TGF-beta antagonists: why suppress a tumor suppressor? | Q34691800 | ||
| Epithelial-mesenchymal transitions: a mesodermal cell strategy for evolutive innovation in Metazoans. | Q34969022 | ||
| Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail | Q34972866 | ||
| Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone | Q35087950 | ||
| TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members | Q35758216 | ||
| Transforming growth factor beta (TGFbeta) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). | Q35846514 | ||
| Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. | Q36118227 | ||
| Transforming growth factor-beta in cancer and metastasis | Q36585129 | ||
| Identification of a negative element in the human vimentin promoter: modulation by the human T-cell leukemia virus type I Tax protein | Q36658429 | ||
| A negative element involved in vimentin gene expression | Q36709129 | ||
| Functional analysis and growth factor regulation of the human vimentin promoter | Q36923398 | ||
| Multiple silencer elements are involved in regulating the chicken vimentin gene | Q38311436 | ||
| Regulation of vimentin by SIP1 in human epithelial breast tumor cells. | Q38314719 | ||
| Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells | Q38332696 | ||
| AP-1/jun binding sites mediate serum inducibility of the human vimentin promoter | Q38345166 | ||
| Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition | Q40224058 | ||
| N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. | Q40296534 | ||
| Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. | Q40299205 | ||
| Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. | Q40584357 | ||
| Association of Vimentin overexpression and hepatocellular carcinoma metastasis | Q40612642 | ||
| Expression profiling of epithelial plasticity in tumor progression | Q40625666 | ||
| Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer | Q40650594 | ||
| Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing | Q40653792 | ||
| Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis | Q40658383 | ||
| Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. | Q40660373 | ||
| Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways | Q40757186 | ||
| Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins | Q40827270 | ||
| An antisilencer element is involved in the transcriptional regulation of the human vimentin gene | Q40961865 | ||
| TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells | Q41164260 | ||
| Regulation of vimentin expression in cultured epithelial cells | Q41591304 | ||
| Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines | Q41601304 | ||
| Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition | Q42126608 | ||
| Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. | Q44124766 | ||
| Osteopontin expression in mammary gland development and tumorigenesis | Q44210778 | ||
| Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines | Q44558518 | ||
| Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling. | Q47381655 | ||
| Analysis of regulatory elements of E-cadherin with reporter gene constructs in transgenic mouse embryos | Q48303624 | ||
| A mouse model of breast cancer metastasis to the choroid of the eye. | Q48534301 | ||
| Functional analysis of chicken vimentin distal promoter regions in cultured lens cells. | Q52223459 | ||
| Detection of mouse osteopontin by western blotting. | Q52532018 | ||
| The prognostic significance of epithelial-mesenchymal transition in breast cancer. | Q52953491 | ||
| Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. | Q53376881 | ||
| Metastasis is driven by sequential elevation of H-ras and Smad2 levels. | Q54297451 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor- Type I Receptor Kinase In vivo | Q59383502 | ||
| Smad protein expression and activation in transforming growth factor-beta refractory human squamous cell carcinoma cells | Q73535713 | ||
| Involvement of histone H4 gene transcription factor 1 in downregulation of vimentin gene expression during skeletal muscle differentiation | Q73558842 | ||
| MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits | Q77103881 | ||
| The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells | Q77228444 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3718-3728 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Experimental Cell Research | Q1524289 |
| P1476 | title | Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta | |
| P478 | volume | 313 |
| Q89287957 | Ablative versus fractionated radiation therapy: a controversial role in cancer invasion and metastasis |
| Q37246530 | Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation |
| Q35135731 | Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice |
| Q45758840 | Expression of the ZEB2 gene in pancreatic stromal cells in pancreatic ductal adenocarcinoma, pancreatitis, and normal state |
| Q38884650 | MTH1 expression is required for effective transformation by oncogenic HRAS. |
| Q42679534 | Precise epitope determination of the anti-vimentin monoclonal antibody V9. |
| Q64994132 | Spinal neural tube closure depends on regulation of surface ectoderm identity and biomechanics by Grhl2. |
| Q43622003 | Spred2 inhibits TGF-beta1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition. |
| Q54751378 | ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression. |
Search more.